2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bansal, S; Chopra, K | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Selective ER-α agonist alleviates vascular endothelial dysfunction in ovariectomized type 2 diabetic rats.
Topics: Acetylcholine; Animals; Aorta; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelium, Vascular; Estradiol; Estrogen Receptor alpha; Female; Glyburide; Inflammation; Lipids; Nitric Oxide Synthase Type III; Nitriles; Nitroprusside; Organ Size; Ovariectomy; Oxidative Stress; Phenols; Phenylephrine; Propionates; Pyrazoles; Rats, Sprague-Dawley; Uterus | 2018 |